InsiderClue
Insiders · Profile

ARCH Venture Partners IX, LLC

10% owner at Lyell Immunopharma · 10% owner at Vir Biotechnology. Filing since 16 Oct 2019. CIK 0001723174

LYEL Lyell Immunopharma, Inc. 10% owner · 1 trade VIR Vir Biotechnology, Inc. 10% owner · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
LYEL Lyell Immunopharma, Inc.
6 Mar 2026
10% owner
Bought
488,090
$12.50M
52.0%
VIR Vir Biotechnology, Inc.
16 Oct 2019
10% owner
Bought
1,000,000
$20.00M
opened
2 decisions on file.